Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T18:28:10.203Z.
Calculation as of: 2026-10-06T18:28:10.203Z.
Quote observation: 2026-10-06T18:25:12.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: b7a441c3924ef4fb7fd11ee72b177fff17d7fc4b92d4d2803dc604c6185f7283
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Relay Therapeutics, Inc.
Market Cap
$4.02B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.03B
Operating Cash Flow Yield
N/A
TTM Avg
5.79%
3Y Avg
6.31%
5Y Avg
5.92%
Market Cap
$3.96B
Operating Cash Flow Yield
5.97%
TTM Avg
4.94%
3Y Avg
5.31%
5Y Avg
4.71%
Market Cap
$4.14B
Operating Cash Flow Yield
6.03%
TTM Avg
6.64%
3Y Avg
5.41%
5Y Avg
4.29%
Market Cap
$3.81B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.32B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.39B
Operating Cash Flow Yield
N/A
TTM Avg
5.97%
3Y Avg
5.97%
5Y Avg
5.97%
Market Cap
$4.43B
Operating Cash Flow Yield
N/A
TTM Avg
6.45%
3Y Avg
5.17%
5Y Avg
5.55%
Market Cap
$4.47B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Relay Therapeutics, Inc. (RLAY) | $4.02B | N/A | N/A | N/A | N/A |
| AbCellera Biologics Inc. (ABCL)vs › | $4.03B | N/A | 5.79% | 6.31% | 5.92% |
| ICU Medical, Inc. (ICUI)vs › | $3.96B | 5.97% | 4.94% | 5.31% | 4.71% |
| LivaNova PLC (LIVN)vs › | $4.14B | 6.03% | 6.64% | 5.41% | 4.29% |
| Regencell Bioscience Holdings Limited (RGC)vs › | $3.81B | N/A | N/A | N/A | N/A |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.32B | N/A | N/A | N/A | N/A |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.39B | N/A | 5.97% | 5.97% | 5.97% |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.43B | N/A | 6.45% | 5.17% | 5.55% |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.47B | N/A | N/A | N/A | N/A |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.56B | 2.41% | 1.69% | 1.34% | 1.34% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
